Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Fractionated Gamma Knife radiosurgery for skull base meningiomas: a single-institution experience.

Joshi KC, Raghavan A, Muhsen B, Hsieh J, Borghei-Razavi H, Chao ST, Barnett GH, Suh JH, Neyman G, Kshettry VR, Recinos PF, Mohammadi AM, Angelov L.

Neurosurg Focus. 2019 Jun 1;46(6):E8. doi: 10.3171/2019.3.FOCUS1963.

PMID:
31153152
2.

Risk Factors for Progression Among Low-Grade Gliomas After Gross Total Resection and Initial Observation in the Molecular Era.

Tom MC, Varra V, Leyrer CM, Park DY, Chao ST, Yu JS, Suh JH, Reddy CA, Balagamwala EH, Broughman JR, Kotagal KA, Vogelbaum MA, Barnett GH, Ahluwalia MS, Peereboom DM, Prayson RA, Stevens GHJ, Murphy ES.

Int J Radiat Oncol Biol Phys. 2019 Apr 22. pii: S0360-3016(19)30631-5. doi: 10.1016/j.ijrobp.2019.04.010. [Epub ahead of print]

PMID:
31022510
3.

Clinical Factors Associated With Cost in Head and Neck Cancer: Implications for a Bundled Payment Model.

Tom MC, Ross RB, Koyfman SA, Adelstein DJ, Lorenz RR, Burkey BB, Shah C, Suh JH, Bolwell BJ, Savage C, Platz S, Ward MC.

J Oncol Pract. 2019 Jun;15(6):e560-e567. doi: 10.1200/JOP.18.00665. Epub 2019 Apr 22.

PMID:
31009283
4.

Updates in the management of intradural spinal cord tumors: a radiation oncology focus.

Kotecha R, Mehta MP, Chang EL, Brown PD, Suh JH, Lo SS, Das S, Samawi HH, Keith J, Perry J, Sahgal A.

Neuro Oncol. 2019 Jun 10;21(6):707-718. doi: 10.1093/neuonc/noz014.

PMID:
30977511
5.

The Impact of Sequencing PD-1/PD-L1 Inhibitors and Stereotactic Radiosurgery for Patients with Brain Metastasis.

Kotecha R, Kim JM, Miller JA, Juloori A, Chao ST, Murphy ES, Peereboom DM, Mohammadi AM, Barnett GH, Vogelbaum MA, Angelov L, Suh JH, Ahluwalia MS.

Neuro Oncol. 2019 Feb 23. pii: noz046. doi: 10.1093/neuonc/noz046. [Epub ahead of print]

PMID:
30796838
6.

Resection First.

Balagamwala EH, Suh JH.

Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):798. doi: 10.1016/j.ijrobp.2018.11.026. No abstract available.

PMID:
30784524
7.

Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.

Parsai S, Miller JA, Juloori A, Chao ST, Kotecha R, Mohammadi AM, Ahluwalia MS, Murphy ES, Barnett GH, Vogelbaum MA, Angelov L, Peereboom DM, Suh JH.

J Neurosurg. 2019 Feb 8:1-9. doi: 10.3171/2018.10.JNS182340. [Epub ahead of print]

PMID:
30738402
8.

Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis.

Kim JM, Miller JA, Kotecha R, Chao ST, Ahluwalia MS, Peereboom DM, Mohammadi AM, Barnett GH, Murphy ES, Vogelbaum MA, Angelov L, Abraham J, Moore H, Budd GT, Suh JH.

Neuro Oncol. 2019 May 6;21(5):659-668. doi: 10.1093/neuonc/noz006.

PMID:
30726965
9.

Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases.

Juloori A, Miller JA, Parsai S, Kotecha R, Ahluwalia MS, Mohammadi AM, Murphy ES, Suh JH, Barnett GH, Yu JS, Vogelbaum MA, Rini B, Garcia J, Stevens GH, Angelov L, Chao ST.

J Neurosurg. 2019 Jan 18:1-9. doi: 10.3171/2018.8.JNS182100. [Epub ahead of print]

PMID:
30660120
10.

Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.

Sharma M, Schroeder JL, Elson P, Meola A, Barnett GH, Vogelbaum MA, Suh JH, Chao ST, Mohammadi AM, Stevens GHJ, Murphy ES, Angelov L.

J Neurosurg. 2018 Oct 1:1-11. doi: 10.3171/2018.4.JNS172909. [Epub ahead of print]

PMID:
30485180
11.

Contemporary Management of 1-4 Brain Metastases.

Sittenfeld SMC, Suh JH, Murphy ES, Yu JS, Chao ST.

Front Oncol. 2018 Sep 24;8:385. doi: 10.3389/fonc.2018.00385. eCollection 2018. Review.

12.

Physician Leadership Development: A Pilot Program for Radiation Oncology Residents.

Berriochoa C, Amarnath S, Berry D, Koyfman SA, Suh JH, Tendulkar RD.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):254-256. doi: 10.1016/j.ijrobp.2018.05.073. No abstract available.

PMID:
30191858
13.

Application of tumor treating fields for newly diagnosed glioblastoma: understanding of nationwide practice patterns.

McClelland S 3rd, Sosanya O, Mitin T, Degnin C, Chen Y, Attia A, Suh JH, Jaboin JJ.

J Neurooncol. 2018 Oct;140(1):155-158. doi: 10.1007/s11060-018-2945-y. Epub 2018 Jul 9.

PMID:
29987746
14.

Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704.

Regine WF, Winter K, Abrams RA, Safran H, Kessel IL, Chen Y, Fugazzi JA, Donnelly ED, DiPetrillo TA, Narayan S, Plastaras JP, Gaur R, Delouya G, Suh JH, Meyer JE, Haddock MG, Didolkar MS, Padula GDA, Johnson D, Hoffman JP, Crane CH.

Adv Radiat Oncol. 2018 Feb 9;3(2):154-162. doi: 10.1016/j.adro.2018.01.003. eCollection 2018 Apr-Jun.

15.

The relationship of study and authorship characteristics on trial sponsorship and self-reported conflicts of interest among neuro-oncology clinical trials.

Raman S, Moraes FY, Mendez LC, Taunk NK, Suh JH, Souhami L, Slotman B, Kongkham P, Spratt DE, Berlin A, Marta GN.

J Neurooncol. 2018 Aug;139(1):195-203. doi: 10.1007/s11060-018-2860-2. Epub 2018 Jun 4.

PMID:
29869023
16.

Pain flare after stereotactic radiosurgery for spine metastases.

Balagamwala EH, Naik M, Reddy CA, Angelov L, Suh JH, Djemil T, Magnelli A, Chao ST.

J Radiosurg SBRT. 2018;5(2):99-105.

17.

Risk Factors for Malignant Transformation of Low-Grade Glioma.

Murphy ES, Leyrer CM, Parsons M, Suh JH, Chao ST, Yu JS, Kotecha R, Jia X, Peereboom DM, Prayson RA, Stevens GHJ, Barnett GH, Vogelbaum MA, Ahluwalia MS.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):965-971. doi: 10.1016/j.ijrobp.2017.12.258. Epub 2017 Dec 21.

PMID:
29485076
18.

Treatment plan quality and delivery accuracy assessments on 3 IMRT delivery methods of stereotactic body radiotherapy for spine tumors.

Huang L, Djemil T, Zhuang T, Andrews M, Chao ST, Suh JH, Xia P.

Med Dosim. 2019 Spring;44(1):11-14. doi: 10.1016/j.meddos.2017.12.009. Epub 2018 Feb 21.

PMID:
29429794
19.

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

Alexander BM, Brown PD, Ahluwalia MS, Aoyama H, Baumert BG, Chang SM, Gaspar LE, Kalkanis SN, Macdonald DR, Mehta MP, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Lee EQ, Wen PY; Response Assessment in Neuro-Oncology (RANO) group.

Lancet Oncol. 2018 Jan;19(1):e33-e42. doi: 10.1016/S1470-2045(17)30692-7. Review.

PMID:
29304360
20.

Recursive partitioning analysis is predictive of overall survival for patients undergoing spine stereotactic radiosurgery.

Balagamwala EH, Miller JA, Reddy CA, Angelov L, Suh JH, Tariq MB, Murphy ES, Yang K, Djemil T, Magnelli A, Mohammadi AM, Soeder S, Chao ST.

J Neurooncol. 2018 Apr;137(2):289-293. doi: 10.1007/s11060-017-2716-1. Epub 2018 Jan 3.

PMID:
29299738
21.

Long-Term Outcome Following Stereotactic Radiosurgery for Glomus Jugulare Tumors: A Single Institution Experience of 20 Years.

Sharma M, Meola A, Bellamkonda S, Jia X, Montgomery J, Chao ST, Suh JH, Angelov L, Barnett GH.

Neurosurgery. 2018 Nov 1;83(5):1007-1014. doi: 10.1093/neuros/nyx566.

PMID:
29228343
22.

Funding source, conflict of interest and positive conclusions in neuro-oncology clinical trials.

Moraes FY, Mendez LC, Taunk NK, Raman S, Suh JH, Souhami L, Slotman B, Weltman E, Spratt DE, Berlin A, Marta GN.

J Neurooncol. 2018 Feb;136(3):585-593. doi: 10.1007/s11060-017-2687-2. Epub 2017 Nov 21. Review.

PMID:
29164521
23.

Training Neurosurgery and Radiation Oncology Residents in Stereotactic Radiosurgery: Assessment Gathered from Participants in AANS and ASTRO Training Course.

Sheehan J, Suh JH, Kavanagh B, Xu Z, Ren L, Sheehan K, Lunsford LD.

World Neurosurg. 2018 Jan;109:e669-e675. doi: 10.1016/j.wneu.2017.10.053. Epub 2017 Oct 20.

PMID:
29061451
24.

Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.

Abbassy M, Missios S, Barnett GH, Brewer C, Peereboom DM, Ahluwalia M, Neyman G, Chao ST, Suh JH, Vogelbaum MA.

Neurosurgery. 2018 Sep 1;83(3):385-392. doi: 10.1093/neuros/nyx369.

PMID:
28973311
25.

Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.

Angelov L, Mohammadi AM, Bennett EE, Abbassy M, Elson P, Chao ST, Montgomery JS, Habboub G, Vogelbaum MA, Suh JH, Murphy ES, Ahluwalia MS, Nagel SJ, Barnett GH.

J Neurosurg. 2018 Aug;129(2):366-382. doi: 10.3171/2017.3.JNS162532. Epub 2017 Sep 22.

PMID:
28937324
26.

Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.

Kotecha R, Miller JA, Venur VA, Mohammadi AM, Chao ST, Suh JH, Barnett GH, Murphy ES, Funchain P, Yu JS, Vogelbaum MA, Angelov L, Ahluwalia MS.

J Neurosurg. 2018 Jul;129(1):50-59. doi: 10.3171/2017.1.JNS162797. Epub 2017 Aug 11.

PMID:
28799876
27.

First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases.

Sharma M, Jia X, Ahluwalia M, Barnett GH, Vogelbaum MA, Chao ST, Suh JH, Murphy ES, Yu JS, Angelov L, Mohammadi AM.

Cancer Med. 2017 Sep;6(9):2076-2086. doi: 10.1002/cam4.1149. Epub 2017 Aug 4.

28.

Reply.

Bellerive C, Aziz HA, Bena J, Wilkinson A, Suh JH, Plesec T, Singh AD.

Am J Ophthalmol. 2017 Sep;181:179-180. doi: 10.1016/j.ajo.2017.06.029. Epub 2017 Jul 26. No abstract available.

PMID:
28755758
29.

Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.

Woody NM, Greer MD, Reddy CA, Videtic GMM, Chao ST, Murphy ES, Suh JH, Angelov L, Barnett GH, Vogelbaum MA, Stephans KL.

Clin Lung Cancer. 2018 Jan;19(1):e141-e147. doi: 10.1016/j.cllc.2017.06.011. Epub 2017 Jul 6.

PMID:
28739316
30.

Cumulative Intracranial Tumor Volume and Number of Brain Metastasis as Predictors of Developing New Lesions After Stereotactic Radiosurgery for Brain Metastasis.

Sharma M, Jia X, Ahluwalia M, Barnett GH, Vogelbaum MA, Chao ST, Suh JH, Murphy ES, Yu JS, Angelov L, Mohammadi AM.

World Neurosurg. 2017 Oct;106:666-675. doi: 10.1016/j.wneu.2017.07.048. Epub 2017 Jul 19.

PMID:
28735139
31.

The impact of decompression with instrumentation on local failure following spine stereotactic radiosurgery.

Miller JA, Balagamwala EH, Berriochoa CA, Angelov L, Suh JH, Benzel EC, Mohammadi AM, Emch T, Magnelli A, Godley A, Qi P, Chao ST.

J Neurosurg Spine. 2017 Oct;27(4):436-443. doi: 10.3171/2017.3.SPINE161015. Epub 2017 Jul 21.

PMID:
28731393
32.

Stereotactic Radiosurgery for Trigeminal Neuralgia Improves Patient-Reported Quality of Life and Reduces Depression.

Kotecha R, Miller JA, Modugula S, Barnett GH, Murphy ES, Reddy CA, Suh JH, Neyman G, Machado A, Nagel S, Chao ST.

Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1078-1086. doi: 10.1016/j.ijrobp.2017.04.008. Epub 2017 Apr 11.

PMID:
28721891
33.

Evaluation of Prognostic Factors for Early Mortality After Stereotactic Radiosurgery for Brain Metastases: a Single Institutional Retrospective Review.

Bennett EE, Vogelbaum MA, Barnett GH, Angelov L, Chao S, Murphy E, Yu J, Suh JH, Elson P, Stevens GHJ, Mohammadi AM.

Neurosurgery. 2018 Jul 1;83(1):128-136. doi: 10.1093/neuros/nyx346.

PMID:
28673040
34.

Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.

Murphy ES, Rogacki K, Godley A, Qi P, Reddy CA, Ahluwalia MS, Peereboom DM, Stevens GH, Yu JS, Kotecha R, Suh JH, Chao ST.

Pract Radiat Oncol. 2017 Nov - Dec;7(6):e391-e399. doi: 10.1016/j.prro.2017.04.003. Epub 2017 Apr 12.

PMID:
28666902
35.

The Prognostic Role of Tumor Volume in the Outcome of Patients with Single Brain Metastasis After Stereotactic Radiosurgery.

Bennett EE, Angelov L, Vogelbaum MA, Barnett GH, Chao ST, Murphy ES, Yu JS, Suh JH, Jia X, Stevens GHJ, Ahluwalia MS, Mohammadi AM.

World Neurosurg. 2017 Aug;104:229-238. doi: 10.1016/j.wneu.2017.04.156. Epub 2017 May 3.

PMID:
28478250
36.

The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies.

Kim JM, Miller JA, Kotecha R, Xiao R, Juloori A, Ward MC, Ahluwalia MS, Mohammadi AM, Peereboom DM, Murphy ES, Suh JH, Barnett GH, Vogelbaum MA, Angelov L, Stevens GH, Chao ST.

J Neurooncol. 2017 Jun;133(2):357-368. doi: 10.1007/s11060-017-2442-8. Epub 2017 Apr 22.

PMID:
28434110
37.

Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.

Wang C, Kaprealian TB, Suh JH, Kubicky CD, Ciporen JN, Chen Y, Jaboin JJ.

Neuro Oncol. 2017 Sep 1;19(9):1263-1270. doi: 10.1093/neuonc/nox007.

38.

Quality of Life following Stereotactic Radiosurgery for Single and Multiple Brain Metastases.

Miller JA, Kotecha R, Barnett GH, Suh JH, Angelov L, Murphy ES, Vogelbaum MA, Mohammadi A, Chao ST.

Neurosurgery. 2017 Jul 1;81(1):147-155. doi: 10.1093/neuros/nyw166.

PMID:
28327994
39.

Three or More Courses of Stereotactic Radiosurgery for Patients with Multiply Recurrent Brain Metastases.

Kotecha R, Damico N, Miller JA, Suh JH, Murphy ES, Reddy CA, Barnett GH, Vogelbaum MA, Angelov L, Mohammadi AM, Chao ST.

Neurosurgery. 2017 Jun 1;80(6):871-879. doi: 10.1093/neuros/nyw147.

PMID:
28327948
40.

The impact of tumor biology on survival and response to radiation therapy among patients with non-small cell lung cancer brain metastases.

Miller JA, Kotecha R, Ahluwalia MS, Mohammadi AM, Suh JH, Barnett GH, Murphy ES, Vogelbaum MA, Angelov L, Chao ST.

Pract Radiat Oncol. 2017 Jul - Aug;7(4):e263-e273. doi: 10.1016/j.prro.2017.01.001. Epub 2017 Jan 5.

PMID:
28254368
41.

Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.

Miller JA, Kotecha R, Ahluwalia MS, Mohammadi AM, Chao ST, Barnett GH, Murphy ES, Vogelbaum MA, Angelov L, Peereboom DM, Suh JH.

Cancer. 2017 Jun 15;123(12):2283-2293. doi: 10.1002/cncr.30616. Epub 2017 Feb 13.

42.

Local Failure After Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors, and Management.

Bellerive C, Aziz HA, Bena J, Wilkinson A, Suh JH, Plesec T, Singh AD.

Am J Ophthalmol. 2017 May;177:9-16. doi: 10.1016/j.ajo.2017.01.024. Epub 2017 Feb 3.

PMID:
28163118
43.

Data-driven management using quantitative metric and automatic auditing program (QMAP) improves consistency of radiation oncology processes.

Yu N, Xia P, Mastroianni A, Kolar MD, Chao ST, Greskovich JF Jr, Suh JH.

Pract Radiat Oncol. 2017 May - Jun;7(3):e215-e222. doi: 10.1016/j.prro.2016.10.014. Epub 2016 Oct 24.

PMID:
28110939
44.

Impact of cervicothoracic region stereotactic spine radiosurgery on adjacent organs at risk.

Sharma M, Bennett EE, Rahmathulla G, Chao ST, Koech HK, Gregory SN, Emch T, Magnelli A, Meola A, Suh JH, Angelov L.

Neurosurg Focus. 2017 Jan;42(1):E14. doi: 10.3171/2016.10.FOCUS16364.

PMID:
28041323
45.

Association of Molecular Marker Status With Graded Prognostic Assessment of Lung Cancer With Brain Metastases.

Suh JH.

JAMA Oncol. 2017 Jun 1;3(6):831-832. doi: 10.1001/jamaoncol.2016.3818. No abstract available.

PMID:
27892988
46.

Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution.

Balasubramanian SK, Sharma M, Silva D, Karivedu V, Schmitt P, Stevens GH, Barnett GH, Prayson RA, Elson P, Suh JH, Murphy ES, Chao ST.

J Neurooncol. 2017 Feb;131(3):555-563. doi: 10.1007/s11060-016-2321-8. Epub 2016 Nov 18.

PMID:
27864703
47.

Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma.

Ahluwalia MS, Bou-Anak S, Burgett ME, Sarmey N, Khosla D, Dahiya S, Weil RJ, Bae E, Huang P, McGraw M, Grove LM, Olman MA, Prayson RA, Suh JH, Gillespie GY, Barnholtz-Sloan J, Nowacki AS, Barnett GH, Gladson CL.

J Neurooncol. 2017 Feb;131(3):449-458. doi: 10.1007/s11060-016-2319-2. Epub 2016 Nov 17.

48.

Spine stereotactic radiosurgery for the treatment of multiple myeloma.

Miller JA, Balagamwala EH, Chao ST, Emch T, Suh JH, Djemil T, Angelov L.

J Neurosurg Spine. 2017 Mar;26(3):282-290. doi: 10.3171/2016.8.SPINE16412. Epub 2016 Oct 28.

PMID:
27791828
49.

Limbal Stem Cell Preservation During Proton Beam Irradiation for Diffuse Iris Melanoma.

Singh AD, Dupps WJ Jr, Biscotti CV, Suh JH, Lathrop KL, Nairn JP, Shih H.

Cornea. 2017 Jan;36(1):119-122.

PMID:
27755196
50.

Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.

Miller JA, Bennett EE, Xiao R, Kotecha R, Chao ST, Vogelbaum MA, Barnett GH, Angelov L, Murphy ES, Yu JS, Ahluwalia MS, Suh JH, Mohammadi AM.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1060-1069. doi: 10.1016/j.ijrobp.2016.08.039. Epub 2016 Sep 1.

PMID:
27742540

Supplemental Content

Loading ...
Support Center